Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PBAM advanced for three days, in of 84 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on November 27, 2024. You may want to consider a long position or call options on PBAM as a result. In of 64 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PBAM just turned positive on December 05, 2024. Looking at past instances where PBAM's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 201 cases where PBAM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
PBAM broke above its upper Bollinger Band on December 05, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PBAM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.117) is normal, around the industry mean (1.030). P/E Ratio (4.909) is within average values for comparable stocks, (18.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.366). Dividend Yield (0.000) settles around the average of (0.058) among similar stocks. P/S Ratio (2.001) is also within normal values, averaging (2.921).
Industry RegionalBanks
A.I.dvisor tells us that PBAM and SQCF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBAM and SQCF's prices will move in lockstep.
Ticker / NAME | Correlation To PBAM | 1D Price Change % | ||
---|---|---|---|---|
PBAM | 100% | N/A | ||
SQCF - PBAM | 30% Poorly correlated | N/A | ||
CBGPY - PBAM | 23% Poorly correlated | N/A | ||
BANF - PBAM | 21% Poorly correlated | -2.68% | ||
PBHC - PBAM | 20% Poorly correlated | -2.90% | ||
PCLB - PBAM | 13% Poorly correlated | N/A | ||
More |